|
 |
Glofil-125.This page contains recent news articles, when available, and an overview of Glofil-125. but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.UNION CITY, Calif. -- Questcor Pharmaceuticals, Inc. (AMEX:QSC) today reported its financial results for the first quarter ended March 31, 2006. ... Free with registration - Business Wire - AccessMyLibrary.com Questcor Announces Financial Results for 2005 and the Expansion of... - Dec 31, 2005 UNION CITY, Calif.--(BUSINESS WIRE)--March 9, 2006--Questcor Pharmaceuticals, Inc. (AMEX:QSC) today reported its financial results for the quarter and year ... businesswire.com Questcor Announces Financial Results for the First Quarter of 2006;... - Mar 31, 2006 UNION CITY, Calif.--(BUSINESS WIRE)--May 9, 2006--Questcor Pharmaceuticals, Inc. (AMEX:QSC) today reported its financial results for the first quarter ended ... businesswire.com Questcor Announces Financial Results for Third Quarter 2005 - Sep 30, 2005 UNION CITY, Calif.--(BUSINESS WIRE)--Oct. 27, 2005--Questcor Pharmaceuticals, Inc. (AMEX:QSC), a specialty pharmaceutical company that develops and ... businesswire.com Financial Results for the Quarter Ended December 31, 2004 - Mar 9, 2005 ...known as esophageal varices; and Glofil-125(R), which is an injectable agent that assesses how well the kidney is working by measuring glomerula. Free with registration - Business Wire - AccessMyLibrary.com Questcor Announces Financial Results for 2005 and the Expansion of... - Mar 9, 2006 UNION CITY, Calif. -- Questcor Pharmaceuticals, Inc. (AMEX:QSC) today reported its financial results for the quarter and year ended December 31, 2005. ... $4.95 - Business Wire - ECNext Questcor Announces the Addition of George Stuart As Chief Financial … - Sep 28, 2005 Questcor Pharmaceuticals, Inc. (AMEX:QSC), a specialty pharmaceutical company, announced today that George Stuart has joined the company as Vice President ... RedOrbit Press Release: FDA Acts to Avoid Shortage and Strengthen the Safety... - Nov 21, 2008 FDA Acts to Avoid Shortage and Strengthen the Safety of Sucraid Agency expedites approval of orphan drug and increases protections forusers. from M2 ... Pay-Per-View - M2 Presswire - HighBeam Research Bellwether Report .com is following Questcor Pharmaceuticals, Inc. - Aug 2, 2006 M2 PRESSWIRE-2 August 2006-bellwetherreport.com: Bellwether Report .com is following Questcor Pharmaceuticals, Inc.(C)1994-2006 M2 COMMUNICATIONS LTD ... $4.95 - M2 Presswire - ECNext Questcor Names James L. Fares President and CEO. - Feb 23, 2005 UNION CITY, Calif. -- Questcor Pharmaceuticals, Inc. (AMEX:QSC), a specialty pharmaceutical company, today announced the appointment of Mr. James L. Fares ... $4.95 - Business Wire - ECNext Questcor Pharmaceuticals Announces New Business Strategy; Company … - Apr 13, 2005 UNION CITY, Calif. & MIAMI -- Questcor Pharmaceuticals, Inc. (AMEX:QSC), a specialty pharmaceutical company, announced today its new business strategy and ... $4.95 - Business Wire - ECNext Questcor to Retire 8% Debentures Following Restructuring of Dividends... - Apr 1, 2005 UNION CITY, Calif. -- Questcor Pharmaceuticals, Inc. (AMEX:QSC), a specialty pharmaceutical company, announced today that it plans to retire all $4 million ... $4.95 - Business Wire - ECNext Questcor Updates Revenue Guidance for 2004 and Reports on Progress … - Feb 18, 2005 UNION CITY, Calif. -- Questcor Pharmaceuticals, Inc. (AMEX:QSC), a specialty pharmaceutical company, announced today that it has revised its revenue ... $4.95 - Business Wire - ECNext Questcor Appoints Gregg Lapointe to Its Board of Directors. - Jul 6, 2005 UNION CITY, Calif. -- Questcor Pharmaceuticals, Inc. (AMEX:QSC), a specialty pharmaceutical company that develops and commercializes novel therapeutics for ... $4.95 - Business Wire - ECNext Questcor Announces First Quarter Earnings Call. - May 9, 2005 UNION CITY, Calif. -- Questcor Pharmaceuticals, Inc. (AMEX:QSC), a specialty pharmaceutical company, will be hosting a conference call to discuss the first ... $4.95 - Business Wire - ECNext Questcor Announces the Addition of Steve Cartt as Executive Vice … - Mar 15, 2005 UNION CITY, Calif. -- Questcor Pharmaceuticals, Inc. (AMEX:QSC), a specialty pharmaceutical company, announced today that Steve Cartt has joined the company ... $4.95 - Business Wire - ECNext Questcor Announces the Addition of Craig Chambliss as Vice President... - May 2, 2005 ...and Glofil-125(R), which is an injectable agent that assesses how well the kidney is working by measuring glomerular filtration rate, or kidney function ... $4.95 - Business Wire - ECNext Questcor Announces FDA Approval of Acthar API Manufacturing Transfer. - Jun 29, 2005 UNION CITY, Calif. -- Questcor Pharmaceuticals, Inc. (AMEX:QSC), a specialty pharmaceutical company that develops and commercializes novel therapeutics for ... $4.95 - Business Wire - ECNext Questcor Announces Year End Earnings Call. - Mar 7, 2005 UNION CITY, Calif. -- Questcor Pharmaceuticals, Inc. (AMEX:QSC), a specialty pharmaceutical company, will be hosting a conference call to discuss the year ... $4.95 - Business Wire - ECNext Questcor Announces Second Quarter Earnings Call. - Aug 9, 2005 UNION CITY, Calif. -- Questcor Pharmaceuticals, Inc. (AMEX:QSC), a specialty pharmaceutical company, will be hosting a conference call to discuss the second ... $4.95 - Business Wire - ECNext Questcor to Announce New Strategic Focus. - Apr 11, 2005 ...and Glofil-125(R), which is an injectable agent that assesses how well the kidney is working by measuring glomerular filtration rate, or kidney function ... $4.95 - Business Wire - ECNext Questcor to Webcast Annual Meeting Presentation. - May 31, 2005 UNION CITY, Calif. -- Questcor Pharmaceuticals, Inc. (AMEX:QSC), today announced that the presentation to be given by James L. Fares, President and Chief ... $4.95 - Business Wire - ECNext |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |